Detection of Brown Adipose Tissue by Magnetic Resonance Imaging
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Sep 9, 2014
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special type of fat in the body called Brown Adipose Tissue (BAT), which may play a role in obesity. The main goal is to see how accurately a type of imaging called MRI can detect BAT compared to another imaging method known as PET. To do this, healthy adults will undergo both MRI and PET scans while in a slightly cold environment, which helps activate BAT.
To participate in this study, you need to be between 18 and 74 years old, have a body mass index (BMI) under 34, and be able to understand and give consent for the study. Unfortunately, if you are pregnant, have certain medical devices like a pacemaker, or have had recent cancer treatments, you won't be able to join. If you participate, you'll experience both MRI and PET scans, which are non-invasive imaging methods, and you'll help researchers learn more about how to detect BAT, potentially contributing to better understanding and treatment of obesity in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Each subject must be fully informed and have signed consent.
- • BMI \< 34
- • Normal neurological and psychological development / able to give consent
- • Willingness to participate in this study
- Exclusion Criteria:
- • Subjects less than 18 years of age
- • Severe claustrophobia
- • Women who are pregnant, nursing an infant or planning to become pregnant in the next 30 days
- • People who have a condition that makes MRI unsafe for them (for example, cardiac pacemaker, epicardial pacemaker leads, cochlear implants, metal aneurysm clip, iron filings in your eyes or metal halo devices)
- • Have had radiation therapy or chemotherapy in the 2 months prior to PET scan
- • Subjects are taking medications that may interfere with BAT detection
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Rosa Tamara Branca, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials